The latest announcement is out from Oramed Pharm ( (ORMP) ).
Oramed has announced the acquisition of a facility as part of its agreement with the government to develop research and production centers, with the acquisition expected to be completed by the end of the year. The agreement signifies a strategic expansion for Oramed, potentially enhancing its capabilities in research and production, which could impact its market position and stakeholder interests positively.
More about Oramed Pharm
YTD Price Performance: -0.41%
Average Trading Volume: 283,521
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $96.75M
For detailed information about ORMP stock, go to TipRanks’ Stock Analysis page.